Targeted Therapy of Bronchiolitis Obliterans Syndrome (FAM for BOS)

Clinical Trial ID NCT01307462

PubWeight™ 4.28‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01307462

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Fluticasone, Azithromycin, and Montelukast Treatment for New-Onset Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant 2015 1.51
2 Pulmonary symptoms measured by the national institutes of health lung score predict overall survival, nonrelapse mortality, and patient-reported outcomes in chronic graft-versus-host disease. Biol Blood Marrow Transplant 2013 1.21
3 A Critical Care and Transplantation-Based Approach to Acute Respiratory Failure after Hematopoietic Stem Cell Transplantation in Children. Biol Blood Marrow Transplant 2015 0.75
4 Fibrotic and sclerotic manifestations of chronic graft-versus-host disease. Biol Blood Marrow Transplant 2012 0.75
Next 100